Ocular Therapeutix, Inc.
Hedge Funds Holdings
Last updated:
Ocular Therapeutix, Inc.‘s stocks are currently a part of 78 hedge funds’ portfolios, which represents 20.52% of the total amount of its stocks outstanding. This makes up a total of 16.95M shares of Ocular Therapeutix, Inc.. Compared to the previous quarter, the number fell by -57.37% or -22.82M shares fewer. As for the holding position changes, 24.36% (19) of current hedge fund investors increased the number of shares held, 30.77% (24) of current holders sold a part of the shares held, and 14.1% (11) closed the holdings completely. 18 hedge funds are new holders of Ocular Therapeutix, Inc. stock in Q1 2023, it is 23.08% of total holders.
Hedge funds holding Ocular Therapeutix (Q2 2018 – Q1 2023)
| Q2 2018 | 68 |
|---|---|
| Q3 2018 | 73 |
| Q4 2018 | 68 |
| Q1 2019 | 67 |
| Q2 2019 | 68 |
| Q3 2019 | 75 |
| Q4 2019 | 78 |
| Q1 2020 | 89 |
| Q2 2020 | 106 |
| Q3 2020 | 106 |
| Q4 2020 | 147 |
| Q1 2021 | 149 |
| Q2 2021 | 145 |
| Q3 2021 | 138 |
| Q4 2021 | 138 |
| Q1 2022 | 129 |
| Q2 2022 | 121 |
| Q3 2022 | 127 |
| Q4 2022 | 116 |
| Q1 2023 | 78 |
Hedge funds changes in Ocular Therapeutix positions (Q2 2018 – Q1 2023)
| Q2 2018 | 11 | 27 | 12 | 8 | 10 |
|---|---|---|---|---|---|
| Q3 2018 | 14 | 23 | 15 | 9 | 12 |
| Q4 2018 | 8 | 26 | 18 | 12 | 4 |
| Q1 2019 | 8 | 26 | 18 | 9 | 6 |
| Q2 2019 | 14 | 23 | 15 | 10 | 6 |
| Q3 2019 | 11 | 29 | 12 | 4 | 19 |
| Q4 2019 | 16 | 21 | 21 | 13 | 7 |
| Q1 2020 | 24 | 26 | 21 | 12 | 6 |
| Q2 2020 | 25 | 53 | 9 | 9 | 10 |
| Q3 2020 | 17 | 39 | 30 | 16 | 4 |
| Q4 2020 | 52 | 48 | 35 | 10 | 2 |
| Q1 2021 | 22 | 55 | 43 | 19 | 10 |
| Q2 2021 | 23 | 58 | 34 | 27 | 3 |
| Q3 2021 | 16 | 46 | 48 | 22 | 6 |
| Q4 2021 | 26 | 52 | 42 | 28 | -10 |
| Q1 2022 | 16 | 44 | 41 | 25 | 3 |
| Q2 2022 | 16 | 40 | 35 | 20 | 10 |
| Q3 2022 | 21 | 44 | 35 | 15 | 12 |
| Q4 2022 | 13 | 39 | 41 | 24 | -1 |
| Q1 2023 | 18 | 19 | 24 | 11 | 6 |
Hedge funds changes in Ocular Therapeutix stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 1,325,000 | 364,000 |
|---|---|---|
| Q3 2018 | 1,410,000 | 787,000 |
| Q4 2018 | 565,000 | 416,000 |
| Q1 2019 | 751,000 | 192,000 |
| Q2 2019 | 1,231,000 | 647,000 |
| Q3 2019 | 506,000 | 441,000 |
| Q4 2019 | 1,218,000 | 186,000 |
| Q1 2020 | 2,952,000 | 535,000 |
| Q2 2020 | 4,721,000 | 2,180,000 |
| Q3 2020 | 1,843,000 | 2,009,000 |
| Q4 2020 | 12,273,000 | 4,963,000 |
| Q1 2021 | 10,257,000 | 9,141,000 |
| Q2 2021 | 24,469,000 | 11,136,000 |
| Q3 2021 | 19,036,000 | 9,556,000 |
| Q4 2021 | 2,103,000 | 2,172,000 |
| Q1 2022 | 771,000 | 883,000 |
| Q2 2022 | 446,000 | 180,000 |
| Q3 2022 | 2,267,000 | 1,383,000 |
| Q4 2022 | 787,841 | 702,928 |
| Q1 2023 | 304,692,000 | 2,814,000 |